Atom Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$841K Sell
55,970
-115,801
-67% -$2.78M 0.05% 412
2026
Q2
$5.74M Buy
171,771
+78,149
+83% +$1.94M 0.51% 20
2026
Q1
$1.96M Buy
+93,622
New +$2.11M 0.14% 251

Other funds holding RARE

Atom Investors's RARE Position: Q3 2026 in Review

Atom Investors reduced its Ultragenyx Pharmaceutical (RARE) stake by 67% in Q3 2026, selling an estimated $2.78M and leaving 55,970 shares worth $841K. The position accounts for 0.05% of the portfolio, ranked #412.

Atom Investors first reported a position in RARE in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.74M in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Atom Investors held 55,970 shares of Ultragenyx Pharmaceutical worth $841K as of Q3 2026.
  • Atom Investors sold 115,801 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $2.78M.
  • Ultragenyx Pharmaceutical made up 0.05% of Atom Investors's portfolio in Q3 2026, its #412 holding.
  • Atom Investors first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • Atom Investors's Ultragenyx Pharmaceutical position peaked at $5.74M in Q2 2026.
  • 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.